000 | 02144 a2200565 4500 | ||
---|---|---|---|
005 | 20250514181333.0 | ||
264 | 0 | _c20040601 | |
008 | 200406s 0 0 eng d | ||
022 | _a0014-827X | ||
024 | 7 |
_a10.1016/j.farmac.2003.08.005 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBruno, Olga | |
245 | 0 | 0 |
_aSynthesis and biological evaluation of neutrophilic inflammation inhibitors. _h[electronic resource] |
260 |
_bFarmaco (Societa chimica italiana : 1989) _cMar 2004 |
||
300 |
_a223-35 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_a3',5'-Cyclic-AMP Phosphodiesterases _xantagonists & inhibitors |
650 | 0 | 4 | _a3',5'-Cyclic-GMP Phosphodiesterases |
650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xchemical synthesis |
650 | 0 | 4 | _aBenzaldehydes |
650 | 0 | 4 | _aBenzoates |
650 | 0 | 4 |
_aBinding, Competitive _xdrug effects |
650 | 0 | 4 | _aCell Separation |
650 | 0 | 4 |
_aCyclic AMP _xmetabolism |
650 | 0 | 4 | _aCyclic Nucleotide Phosphodiesterases, Type 3 |
650 | 0 | 4 | _aCyclic Nucleotide Phosphodiesterases, Type 4 |
650 | 0 | 4 | _aCyclic Nucleotide Phosphodiesterases, Type 5 |
650 | 0 | 4 | _aCyclopentanes |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHydroxybenzoate Ethers |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 | _aIndicators and Reagents |
650 | 0 | 4 |
_aNeutrophils _xdrug effects |
650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xmetabolism |
650 | 0 | 4 |
_aPhosphoric Diester Hydrolases _xmetabolism |
650 | 0 | 4 |
_aRolipram _xmetabolism |
650 | 0 | 4 |
_aSuperoxides _xmetabolism |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
700 | 1 | _aBrullo, Chiara | |
700 | 1 | _aArduino, Nicoletta | |
700 | 1 | _aSchenone, Silvia | |
700 | 1 | _aRanise, Angelo | |
700 | 1 | _aBondavalli, Francesco | |
700 | 1 | _aOttonello, Luciano | |
700 | 1 | _aDapino, Patrizia | |
700 | 1 | _aDallegri, Franco | |
773 | 0 |
_tFarmaco (Societa chimica italiana : 1989) _gvol. 59 _gno. 3 _gp. 223-35 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.farmac.2003.08.005 _zAvailable from publisher's website |
999 |
_c14709042 _d14709042 |